Stephen J. Kogut, PhD MBA RPh

  • Professor
  • Office: SSRC 138
  • Phone: 401.874.5370
  • Email: kogut@uri.edu
  • Office Location: Avedisian Hall, 7 Greenhouse Road, Kingston, RI 02881
  • ResearchGate

Biography

Stephen J. Kogut, PhD, MBA, RPh is Vice Chair of the Department of Pharmacy Practice and Clinical Research. Dr. Kogut specializes in medication outcomes research, and teaches and conducts studies examining the real-world effectiveness, safety and costs of prescription drugs. He began his professional career with Harvard Pilgrim Health Plan of New England, where he contributed to developing and implementing drug management protocols. Dr. Kogut served as project manager for the Study of Clinically Relevant Indicators for Pharmacologic Therapy (the SCRIPT Project), a national initiative led by the Coalition for Quality in Medication Use and sponsored by the Centers for Medicare & Medicaid Services (CMS). He served as an expert panelist for CMS in its efforts to define quality measures for the Part D drug program, and he contributed to the National Quality Forum’s National Voluntary Consensus Standards for Therapeutic Drug Management Quality. Dr. Kogut is a former member and interim Director of the Rhode Island Board of Pharmacy. In 2021, as a Visiting Fellow at the Institute for Clinical and Economic Review (ICER), he explored how pricing dynamics during the drug life cycle influence cost-effectiveness analyses. He is a current member of the Rhode Island Medicaid Drug Utilization Review Board, the AMCP Format for Formulary Submissions Committee, and the Pharmacy Quality Alliance Quality Innovation and Research Center Advisory Committee. He practiced as a pharmacist for more than 30 years.

Research

Medication Use in Populations, Drug Quality and Safety, Pharmacoecononomics

Education

Ph.D., University of Rhode Island, 2001
M.B.A., Bryant University, 1998
B.S. Pharmacy, University of Rhode Island, 1991

Selected Publications

Kogut SJ. A primer on quality measurement and reporting in pharmacy benefit plans. J Manag Care Spec Pharm. 2024 Apr;30(4):386-396.

Borrelli EP, Bratberg J, Greaney ML, Kogut SJ. Tramadol utilization among patients with higher risk of adverse drug events: A claims analysis of commercially insured and Medicare Advantage members. J Opioid Manag. 2023 May-Jun;19(3):257-271.

Kimberly JA, Kogut SJ, Stevenson JF, et al. Researcher Views of Barriers to Clinical and Translational Research in a Statewide Program. Eval Health Prof. 2023 Apr 8:1632787231167942.

Kogut SJ, Campbell JD, Pearson SD. The Influence of US Drug Price Dynamics on Cost-Effectiveness Analyses of Biologics. Value Health. 2023 Mar;26(3):378-383.

Finke W, Kogut SJ. Rhode Island Has the Highest Rate of Medicare Part D Claims for Benzodiazepines Among New England States. R I Med J. 2023 Mar 1;106(2):22-26.

Shah KK, Caffrey AR, Szczotka A, Belazi D, Kogut SJ. Real-world utilization of top-down and step-up therapy and initial costs in Crohn disease. J Manag Care Spec Pharm. 2022 Aug;28(8):849-861.

Kogut SJ. Racial disparities in medication use: imperatives for managed care pharmacy. J Manag Care Spec Pharm. 2020 Nov;26(11):1468-1474. doi: 10.18553/jmcp.2020.26.11.1468.